Modulight Oyj (MODU.HE)
EUR 1.24
(-2.97%)
EUR 1.24
(-2.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -10.44 Million EUR | -81.08% |
| 2022 | -6.71 Million EUR | -78.06% |
| 2021 | -3.68 Million EUR | -163.57% |
| 2020 | 5.76 Million EUR | 29.99% |
| 2019 | 4.46 Million EUR | 37.72% |
| 2018 | 3.24 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -164 Thousand EUR | 69.26% |
| 2024 Q2 | -245 Thousand EUR | 10.55% |
| 2024 Q3 | -1.09 Million EUR | -3.21% |
| 2023 FY | - EUR | -81.08% |
| 2023 Q4 | -3.85 Million EUR | 0.0% |
| 2023 Q1 | -1.42 Million EUR | 30.56% |
| 2023 Q3 | -3.85 Million EUR | -146.93% |
| 2023 Q2 | -1.56 Million EUR | -9.24% |
| 2022 Q3 | -2.05 Million EUR | 4.99% |
| 2022 Q4 | -2.05 Million EUR | 0.0% |
| 2022 FY | - EUR | -78.06% |
| 2022 Q2 | -2.16 Million EUR | -66.94% |
| 2022 Q1 | -1.29 Million EUR | 17.38% |
| 2021 Q4 | -1.57 Million EUR | -3.7% |
| 2021 FY | - EUR | -163.57% |
| 2021 Q3 | -1.51 Million EUR | -184.8% |
| 2021 Q2 | 1.78 Million EUR | 13.11% |
| 2021 Q1 | 1.57 Million EUR | -65.1% |
| 2020 Q3 | 1.27 Million EUR | 0.0% |
| 2020 FY | - EUR | 29.99% |
| 2020 Q4 | 4.52 Million EUR | 254.62% |
| 2019 FY | - EUR | 37.72% |
| 2018 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BBS-Bioactive Bone Substitutes Oyj | -3.14 Million EUR | -231.622% |
| Nexstim Plc | -935.5 Thousand EUR | -1016.507% |
| Revenio Group Oyj | 30.09 Million EUR | 134.713% |